Xylem Inc. Website

Xylem Inc.

NYSE-XYL

Basic

  • Market Cap

    $33.25B

  • EV

    $34.68B

  • Shares Out

    242.45M

  • Revenue

    $7,949M

  • Employees

    23,000

Margins

  • Gross

    36.77%

  • EBITDA

    18.13%

  • Operating

    11.71%

  • Pre-Tax

    8.87%

  • Net

    8.34%

  • FCF

    8.16%

Returns (5Yr Avg)

  • ROA

    4.65%

  • ROTA

    18.5%

  • ROE

    11.71%

  • ROCE

    9.11%

  • ROIC

    8.55%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $150.76

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    $947M

  • Net Debt

    $1,427M

  • Debt/Equity

    0.23

  • EBIT/Interest

    17.24

Growth (CAGR)

  • Rev 3Yr

    16.64%

  • Rev 5Yr

    8.75%

  • Rev 10Yr

    7.48%

  • Dil EPS 3Yr

    19.38%

  • Dil EPS 5Yr

    -1.28%

  • Dil EPS 10Yr

    8.39%

  • Rev Fwd 2Yr

    10.74%

  • EBITDA Fwd 2Yr

    17.23%

  • EPS Fwd 2Yr

    12.2%

  • EPS LT Growth Est

    13.55%

Dividends

  • Yield

    —

  • Payout

    47.32%

  • DPS

    $1.35

  • DPS Growth 3Yr

    8.4%

  • DPS Growth 5Yr

    9.19%

  • DPS Growth 10Yr

    10.96%

  • DPS Growth Fwd 2Yr

    7.89%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Metric
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Total Revenues

5,249

4,876

5,195

5,522

7,364

7,949

Total Revenues % Chg.

0.8%

-7.1%

6.5%

6.3%

33.4%

39.5%

Cost of Goods Sold, Total

3,203

3,046

3,220

3,438

4,647

5,026

Gross Profit

2,046

1,830

1,975

2,084

2,717

2,923

Selling General & Admin Expenses, Total

1,165

1,158

1,193

1,237

1,633

1,754

R&D Expenses

191

187

204

206

232

238

Other Operating Expenses, Total

1,356

1,345

1,397

1,443

1,865

1,992

Operating Income

690

485

578

641

852

931

Interest Expense, Total

-67

-77

-76

-50

-49

-54

Interest And Investment Income

5

7

7

16

28

28

Net Interest Expenses

-62

-70

-69

-34

-21

-26

Income (Loss) On Equity Invest.

3

2

9

—

—

—

Other Non Operating Income (Expenses)

-5

1

-2

1

7

10

EBT, Excl. Unusual Items

626

418

516

608

838

915

Restructuring Charges

-53

-54

-6

-15

-72

-75

Merger & Related Restructuring Charges

—

—

—

—

—

—

—

-126

-126

Impairment of Goodwill

—

—

—

—

—

-148

-58

—

—

—

—

Gain (Loss) On Sale Of Assets

—

—

1

—

2

1

-1

-6

Asset Writedown

—

—

—

-10

-21

-1

-14

-4

-3

Other Unusual Items

—

—

—

—

—

—

—

—

-140

—

—

EBT, Incl. Unusual Items

416

285

511

440

635

705

Income Tax Expense

15

31

84

85

26

42

Earnings From Continuing Operations

401

254

427

355

609

663

Minority Interest

—

—

—

—

—

—

—

—

—

—

Net Income

401

254

427

355

609

663

Net Income to Common Incl Extra Items

401

254

427

355

609

663

Net Income to Common Excl. Extra Items

401

254

427

355

609

663

Total Shares Outstanding

180.1

180.4

180.4

180.3

241.5

242.5

Weighted Avg. Shares Outstanding

180

180.1

180.2

180.2

217

232.4

Weighted Avg. Shares Outstanding Dil

181.2

181.1

181.5

181

218.2

233.6

EPS

2.2

1.4

2.4

2

2.8

2.9

EPS Diluted

2.2

1.4

2.4

2

2.8

2.8

EBITDA

947

736

824

880

1,288

1,441

Effective Tax Rate

3.6%

10.9%

16.4%

19.3%

4.1%

6%